Division of Human Nutrition, Wageningen University and Research, Wageningen, Netherlands.
Institute of Nutrition, Mahidol University, Nakhon Pathom, Thailand.
Front Endocrinol (Lausanne). 2020 Oct 6;11:572984. doi: 10.3389/fendo.2020.572984. eCollection 2020.
Iodine deficiency during pregnancy may be associated with lower offspring IQ, but there are few data on the safety and efficacy of maternal iodine supplementation on child development. In a previously reported multi-center randomized trial conducted in Thailand and India, we assessed the effect of iodine supplementation in mildly iodine-deficient pregnant women on offspring development. In this secondary analysis of that trial, we report data only from the Thai pregnant women in the study, who were more iodine deficient at entry. Pregnant women in Bangkok, Thailand, were randomized to receive daily 200 μg oral iodine or placebo until delivery. We assessed thyroid size and thyroid function during pregnancy and cognitive and motor development at ages 1, 2, and 5.7 years. The trial was registered at www.clinicaltrials.gov/NCT00791466. Women ( = 514) entered the trial between November 2008 and March 2011 at a mean ± SD gestational age of 11 ± 2.8 weeks; their median (IQR) UIC was 112 (75, 170) μg/L. Mean compliance with supplementation was 88%. We assessed 397 mothers in the 3rd trimester, 231 infants at age 2 y, and 157 children at mean age 5.7 y. During pregnancy, there was a slightly greater decrease in free and total thyroxine concentrations in the iodine group ( < 0.05). At age 2 years, the iodine group had borderline lower scores for combined fine and gross motor function ( = 0.05), but there were no other significant differences in development. At 5.7 years, there were no significant group differences in child development. Daily iodine supplementation in mildly iodine deficient pregnant women was associated with small negative effects on maternal thyroxine concentrations, but did not affect child development. The safety and efficacy of iodine supplementation in mildly-iodine deficient pregnant women needs to be evaluated further in large randomized controlled trials.
孕妇碘缺乏可能与后代智商降低有关,但关于母体碘补充对儿童发育的安全性和有效性的数据很少。在之前在泰国和印度进行的一项多中心随机试验中,我们评估了轻度碘缺乏的孕妇补充碘对后代发育的影响。在该试验的二次分析中,我们仅报告了研究中泰国孕妇的数据,这些孕妇在入组时碘缺乏更为严重。曼谷的孕妇被随机分配接受每日 200μg 口服碘或安慰剂,直至分娩。我们在妊娠期间评估甲状腺大小和甲状腺功能,并在 1、2 和 5.7 岁时评估认知和运动发育。该试验在 www.clinicaltrials.gov/NCT00791466 注册。
514 名女性于 2008 年 11 月至 2011 年 3 月在平均 ± SD 妊娠 11 ± 2.8 周时进入试验;其平均(SD)UIC 中位数(IQR)为 112(75,170)μg/L。补充剂的平均依从率为 88%。我们在妊娠晚期评估了 397 名母亲,2 岁时评估了 231 名婴儿,平均年龄 5.7 岁时评估了 157 名儿童。在妊娠期间,碘组游离和总甲状腺素浓度略有下降(<0.05)。2 岁时,碘组的精细和粗大运动功能综合评分略低(=0.05),但发育无其他显著差异。5.7 岁时,两组儿童发育无显著差异。
轻度碘缺乏的孕妇每天补充碘与母体甲状腺素浓度的轻微负面影响有关,但不影响儿童发育。在大规模随机对照试验中需要进一步评估轻度碘缺乏孕妇补充碘的安全性和有效性。